Logo image of IMCD.AS

IMCD NV (IMCD.AS) Stock Fundamental Analysis

AMS:IMCD - Euronext Amsterdam - NL0010801007 - Common Stock - Currency: EUR

131.35  +1.7 (+1.31%)

Fundamental Rating

6

Overall IMCD gets a fundamental rating of 6 out of 10. We evaluated IMCD against 16 industry peers in the Trading Companies & Distributors industry. IMCD scores excellent on profitability, but there are some minor concerns on its financial health. IMCD has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

IMCD had positive earnings in the past year.
In the past year IMCD had a positive cash flow from operations.
Each year in the past 5 years IMCD has been profitable.
Each year in the past 5 years IMCD had a positive operating cash flow.
IMCD.AS Yearly Net Income VS EBIT VS OCF VS FCFIMCD.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.70%, IMCD belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
With a decent Return On Equity value of 12.57%, IMCD is doing good in the industry, outperforming 68.75% of the companies in the same industry.
IMCD has a Return On Invested Capital of 8.08%. This is in the better half of the industry: IMCD outperforms 68.75% of its industry peers.
IMCD had an Average Return On Invested Capital over the past 3 years of 9.57%. This is in line with the industry average of 8.56%.
Industry RankSector Rank
ROA 5.7%
ROE 12.57%
ROIC 8.08%
ROA(3y)7.11%
ROA(5y)6.42%
ROE(3y)16.08%
ROE(5y)14.41%
ROIC(3y)9.57%
ROIC(5y)8.66%
IMCD.AS Yearly ROA, ROE, ROICIMCD.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

IMCD has a better Profit Margin (5.89%) than 93.75% of its industry peers.
In the last couple of years the Profit Margin of IMCD has grown nicely.
IMCD's Operating Margin of 8.99% is amongst the best of the industry. IMCD outperforms 87.50% of its industry peers.
In the last couple of years the Operating Margin of IMCD has grown nicely.
Looking at the Gross Margin, with a value of 22.49%, IMCD is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
IMCD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.99%
PM (TTM) 5.89%
GM 22.49%
OM growth 3Y0.9%
OM growth 5Y6.54%
PM growth 3Y-0.83%
PM growth 5Y7.95%
GM growth 3Y1.7%
GM growth 5Y2.81%
IMCD.AS Yearly Profit, Operating, Gross MarginsIMCD.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

5

2. Health

2.1 Basic Checks

IMCD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
IMCD has more shares outstanding than it did 1 year ago.
IMCD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, IMCD has an improved debt to assets ratio.
IMCD.AS Yearly Shares OutstandingIMCD.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
IMCD.AS Yearly Total Debt VS Total AssetsIMCD.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

IMCD has an Altman-Z score of 3.52. This indicates that IMCD is financially healthy and has little risk of bankruptcy at the moment.
IMCD's Altman-Z score of 3.52 is fine compared to the rest of the industry. IMCD outperforms 68.75% of its industry peers.
The Debt to FCF ratio of IMCD is 7.15, which is on the high side as it means it would take IMCD, 7.15 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.15, IMCD is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
IMCD has a Debt/Equity ratio of 0.63. This is a neutral value indicating IMCD is somewhat dependend on debt financing.
The Debt to Equity ratio of IMCD (0.63) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 7.15
Altman-Z 3.52
ROIC/WACC1.23
WACC6.56%
IMCD.AS Yearly LT Debt VS Equity VS FCFIMCD.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.98 indicates that IMCD should not have too much problems paying its short term obligations.
IMCD's Current ratio of 1.98 is in line compared to the rest of the industry. IMCD outperforms 56.25% of its industry peers.
A Quick Ratio of 1.29 indicates that IMCD should not have too much problems paying its short term obligations.
IMCD's Quick ratio of 1.29 is fine compared to the rest of the industry. IMCD outperforms 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.29
IMCD.AS Yearly Current Assets VS Current LiabilitesIMCD.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

IMCD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.57%, which is quite good.
IMCD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.23% yearly.
The Revenue has been growing slightly by 6.41% in the past year.
The Revenue has been growing by 14.91% on average over the past years. This is quite good.
EPS 1Y (TTM)10.57%
EPS 3Y24.2%
EPS 5Y21.23%
EPS Q2Q%-3.47%
Revenue 1Y (TTM)6.41%
Revenue growth 3Y13.03%
Revenue growth 5Y14.91%
Sales Q2Q%7.52%

3.2 Future

IMCD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.07% yearly.
IMCD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.87% yearly.
EPS Next Y85.49%
EPS Next 2Y28.3%
EPS Next 3Y18.62%
EPS Next 5Y15.07%
Revenue Next Year35.8%
Revenue Next 2Y15.63%
Revenue Next 3Y12.07%
Revenue Next 5Y9.87%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IMCD.AS Yearly Revenue VS EstimatesIMCD.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
IMCD.AS Yearly EPS VS EstimatesIMCD.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 35.89, IMCD can be considered very expensive at the moment.
IMCD's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.90, IMCD is valued a bit more expensive.
Based on the Price/Forward Earnings ratio of 21.80, the valuation of IMCD can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IMCD is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 21.58. IMCD is around the same levels.
Industry RankSector Rank
PE 35.89
Fwd PE 21.8
IMCD.AS Price Earnings VS Forward Price EarningsIMCD.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

IMCD's Enterprise Value to EBITDA ratio is in line with the industry average.
IMCD's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 30.72
EV/EBITDA 16.1
IMCD.AS Per share dataIMCD.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

IMCD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IMCD has an outstanding profitability rating, which may justify a higher PE ratio.
IMCD's earnings are expected to grow with 18.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.42
PEG (5Y)1.69
EPS Next 2Y28.3%
EPS Next 3Y18.62%

More info and screens

3

5. Dividend

5.1 Amount

IMCD has a Yearly Dividend Yield of 1.66%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.66, IMCD has a dividend in line with its industry peers.
IMCD's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.66%

5.2 History

The dividend of IMCD is nicely growing with an annual growth rate of 22.38%!
Dividend Growth(5Y)22.38%
Div Incr Years1
Div Non Decr Years1
IMCD.AS Yearly Dividends per shareIMCD.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

IMCD pays out 45.88% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of IMCD is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP45.88%
EPS Next 2Y28.3%
EPS Next 3Y18.62%
IMCD.AS Yearly Income VS Free CF VS DividendIMCD.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
IMCD.AS Dividend Payout.IMCD.AS Dividend Payout, showing the Payout Ratio.IMCD.AS Dividend Payout.PayoutRetained Earnings

More info and screens

IMCD NV

AMS:IMCD (3/14/2025, 7:00:00 PM)

131.35

+1.7 (+1.31%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)03-05 2025-03-05/bmo
Earnings (Next)04-25 2025-04-25
Inst Owners75.23%
Inst Owner ChangeN/A
Ins Owners1.7%
Ins Owner ChangeN/A
Market Cap7.76B
Analysts77.39
Price Target167.76 (27.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.66%
Yearly Dividend2.2
Dividend Growth(5Y)22.38%
DP45.88%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.48%
Min EPS beat(2)-15.97%
Max EPS beat(2)7.01%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.83%
Min Revenue beat(2)-2.59%
Max Revenue beat(2)-1.07%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.86%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)1.46%
Valuation
Industry RankSector Rank
PE 35.89
Fwd PE 21.8
P/S 1.64
P/FCF 30.72
P/OCF 27.81
P/B 3.51
P/tB N/A
EV/EBITDA 16.1
EPS(TTM)3.66
EY2.79%
EPS(NY)6.02
Fwd EY4.59%
FCF(TTM)4.28
FCFY3.26%
OCF(TTM)4.72
OCFY3.6%
SpS79.98
BVpS37.45
TBVpS-6.68
PEG (NY)0.42
PEG (5Y)1.69
Profitability
Industry RankSector Rank
ROA 5.7%
ROE 12.57%
ROCE 11.09%
ROIC 8.08%
ROICexc 9.36%
ROICexgc 44.32%
OM 8.99%
PM (TTM) 5.89%
GM 22.49%
FCFM 5.35%
ROA(3y)7.11%
ROA(5y)6.42%
ROE(3y)16.08%
ROE(5y)14.41%
ROIC(3y)9.57%
ROIC(5y)8.66%
ROICexc(3y)10.67%
ROICexc(5y)9.54%
ROICexgc(3y)40.09%
ROICexgc(5y)35.52%
ROCE(3y)14.12%
ROCE(5y)13.14%
ROICexcg growth 3Y11.47%
ROICexcg growth 5Y12.83%
ROICexc growth 3Y2.19%
ROICexc growth 5Y4.08%
OM growth 3Y0.9%
OM growth 5Y6.54%
PM growth 3Y-0.83%
PM growth 5Y7.95%
GM growth 3Y1.7%
GM growth 5Y2.81%
F-Score5
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 7.15
Debt/EBITDA 2.49
Cap/Depr 19.36%
Cap/Sales 0.56%
Interest Coverage 6.94
Cash Conversion 49.71%
Profit Quality 90.84%
Current Ratio 1.98
Quick Ratio 1.29
Altman-Z 3.52
F-Score5
WACC6.56%
ROIC/WACC1.23
Cap/Depr(3y)23.75%
Cap/Depr(5y)23.21%
Cap/Sales(3y)0.62%
Cap/Sales(5y)0.61%
Profit Quality(3y)103.46%
Profit Quality(5y)114.83%
High Growth Momentum
Growth
EPS 1Y (TTM)10.57%
EPS 3Y24.2%
EPS 5Y21.23%
EPS Q2Q%-3.47%
EPS Next Y85.49%
EPS Next 2Y28.3%
EPS Next 3Y18.62%
EPS Next 5Y15.07%
Revenue 1Y (TTM)6.41%
Revenue growth 3Y13.03%
Revenue growth 5Y14.91%
Sales Q2Q%7.52%
Revenue Next Year35.8%
Revenue Next 2Y15.63%
Revenue Next 3Y12.07%
Revenue Next 5Y9.87%
EBIT growth 1Y-0.8%
EBIT growth 3Y12.24%
EBIT growth 5Y19.26%
EBIT Next Year30.36%
EBIT Next 3Y15.18%
EBIT Next 5Y13.52%
FCF growth 1Y-33.93%
FCF growth 3Y12.49%
FCF growth 5Y10.07%
OCF growth 1Y-33.52%
OCF growth 3Y12.47%
OCF growth 5Y9.9%